WW
UTHR icon

Winnow Wealth’s United Therapeutics UTHR Stock Holding History

Winnow Wealth’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$962K Sell
1,776
-48
-3% -$27K 0.65% 45
2026
Q1 		$1.08M Sell
1,824
-148
-8% -$73.7K 0.83% 28
2025
Q4 		$962K Buy
+1,972
New +$918K 0.71% 43

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Winnow Wealth's UTHR Position: Q2 2026 in Review

Winnow Wealth reduced its United Therapeutics (UTHR) stake by 2.6% in Q2 2026, selling an estimated $27K and leaving 1,776 shares worth $962K. The position accounts for 0.65% of the portfolio, ranked #45.

Winnow Wealth first reported a position in UTHR in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.08M in Q1 2026. 879 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Winnow Wealth held 1,776 shares of United Therapeutics worth $962K as of Q2 2026.
  • Winnow Wealth sold 48 United Therapeutics shares in Q2 2026, an estimated $27K.
  • United Therapeutics made up 0.65% of Winnow Wealth's portfolio in Q2 2026, its #45 holding.
  • Winnow Wealth first reported a position in United Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Winnow Wealth's United Therapeutics position peaked at $1.08M in Q1 2026.
  • 879 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Winnow Wealth's 13F filing for Q2 2026, filed 22 Jul 2026.